000			01686 a2200445 4500
005			20250515153851.0
264		0	_c20090220
008			200902s 0 0 eng d
022			_a0890-9091
040			_aNLM _beng _cNLM
100	1		_aHann, Christine L
245	0	0	_aManagement of small-cell lung cancer: incremental changes but hope for the future. _h[electronic resource]
260			_bOncology (Williston Park, N.Y.) _cNov 2008
300			_a1486-92 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Comment
650	0	4	_aAnthracyclines _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xmetabolism
650	0	4	_aBrain Neoplasms _xprevention & control
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aClinical Trials, Phase II as Topic
650	0	4	_aCranial Irradiation
650	0	4	_aDose Fractionation, Radiation
650	0	4	_aEtoposide _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aNeoplasm Staging
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aPrognosis
650	0	4	_aRadiotherapy, Adjuvant
650	0	4	_aRadiotherapy, High-Energy _xmethods
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aSmall Cell Lung Carcinoma _xdrug therapy
650	0	4	_aSurvival Analysis
650	0	4	_aTopotecan _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aRudin, Charles M
773	0		_tOncology (Williston Park, N.Y.) _gvol. 22 _gno. 13 _gp. 1486-92
999			_c18582469 _d18582469